Colorectal Tumors
Preclinical data supports development of OXi4503 for colorectal tumors
Published in Clinical Oncology Week, May 16th, 2005
"We believe that the positive presentations and quality of data on OXiGENE's vascular targeting agents made by our collaborators as well as independent researchers at this year's AACR annual meeting validate the promise of these product candidates," stated Frederick W. Driscoll, president and chief executive officer of OXiGENE. "OXiGENE has two novel clinical candidates, CA4P and OXi4503, in development; placing us at the forefront of this...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Chemotherapy
Surgery and chemotherapy for peritoneal colorectal carcinomatosis assessed - Colorectal Cancer
FOLFOX improved convenience in untreated metastatic colorectal cancer patients - Complementary & Alternative Medicine
Herbal medicine may alter cell response to breast cancer drugs - Head & Neck Cancers
Patient and tumor factors associated with advanced carcinomas of head and neck - Human Papillomavirus
High-throughput, rapid, single-tube, HPV genotyping assay developed - Acute Cardiac Ischemia
Pharma company advances compound for diagnosis of acute cardiac ischemia - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
